No. 18-1515

Eli Lilly and Company v. Erfindergemeinschaft UroPep GbR

Lower Court: Federal Circuit
Docketed: 2019-06-06
Status: Denied
Type: Paid
Amici (3)Response RequestedResponse WaivedRelisted (2) Experienced Counsel
Tags: 35-usc-112 ariad-pharmaceuticals claim-construction enablement functional-claiming halliburton-oil-well-cementing halliburton-oil-well-cementing-co-v-walker halliburton-precedent patent-claims patent-eligibility patent-law point-of-novelty single-step-claim written-description
Key Terms:
Antitrust Patent
Latest Conference: 2019-10-18 (distributed 2 times)
Question Presented (AI Summary)

Whether a single-step patent claim that describes its point of novelty solely in functional terms violates the rule against functional claiming

Question Presented (OCR Extract)

QUESTION PRESENTED Whether a single-step patent claim that describes its point of novelty solely in functional terms violates the rule against functional claiming set forth in Halliburton Oil Well Cementing Co. v. Walker, 329 U.S. 1 (1946). (I)

Docket Entries

2019-10-21
Petition DENIED.
2019-10-02
DISTRIBUTED for Conference of 10/18/2019.
2019-10-02
Reply of petitioner Eli Lilly and Company filed. (Distributed)
Main DocumentProof of ServiceCertificate of Word Count
2019-09-18
Brief of respondent Erfindergemeinschaft UroPep GbR in opposition filed.
Main DocumentCertificate of Word CountCertificate of Word Count
2019-08-19
Response Requested. (Due September 18, 2019)
2019-07-08
Brief amicus curiae of High Tech Inventors Alliance filed. (Distributed)
Main DocumentCertificate of Word CountProof of Service
2019-07-08
Brief amici curiae of Eisai Co., Ltd., et al. filed. (Distributed)
Main DocumentCertificate of Word CountProof of Service
2019-07-08
Brief amici curiae of Sanofi, Sanofi-Aventis U.S. LLC, et al. filed. (Distributed)
Main DocumentCertificate of Word CountProof of Service
2019-06-12
DISTRIBUTED for Conference of 10/1/2019.
2019-06-06
Waiver of right of respondent Erfindergemeinschaft UroPep GbR to respond filed.
Main Document
2019-06-05
Petition for a writ of certiorari filed. (Response due July 8, 2019)
PetitionAppendixProof of ServiceCertificate of Word Count
2019-04-25
Application (18A1084) granted by The Chief Justice extending the time to file until June 5, 2019.
2019-04-22
Application (18A1084) to extend the time to file a petition for a writ of certiorari from May 6, 2019 to June 5, 2019, submitted to The Chief Justice.
Main DocumentLower Court Orders/OpinionsProof of Service

Attorneys

Eisai Inc.
Stephen Blake Kinnaird — Paul Hastings LLP, Amicus
Stephen Blake Kinnaird — Paul Hastings LLP, Amicus
Eli Lilly and Company
Kannon K. Shanmugam — Paul, Weiss, Rifkind, Wharton & Garrison LLP, Petitioner
Kannon K. Shanmugam — Paul, Weiss, Rifkind, Wharton & Garrison LLP, Petitioner
Erfindergemeinschaft UroPep GbR
Adam Karl Mortara — Bartlit Beck LLP, Respondent
Adam Karl Mortara — Bartlit Beck LLP, Respondent
High Tech Inventors Alliance
Ginger D. Anders — Munger, Tolles & Olson LLP, Amicus
Ginger D. Anders — Munger, Tolles & Olson LLP, Amicus
Sanofi, Sanofi-Aventis U.S. LLC, Aventisub LLC, f/d/b/a Aventis Pharmaceuticals Inc., and Regeneron Pharmaceuticals, Inc.
George William Hicks Jr. — Kirkland & Ellis LLP, Amicus
George William Hicks Jr. — Kirkland & Ellis LLP, Amicus